Skip to main content

FDA issues warning letters to 2 CBD brands marketing violations

Honest Globe and Biolyte Labs received letters for their marketing practices, as well as for substandard manufacturing practices, according to the Food and Drug Administration.
salazar

The Food and Drug Administration has sent warning letters to two companies for selling products with CBD in ways that violate the federal Food, Drug and Cosmetic Act. Honest Globe and Biolyte Labs received letters because CBD cannot be legally marketed as an inactive ingredient in OTC drug products that haven’t been reviewed and approved by the FDA, as well as substandard manufacturing practices. 

"The FDA continues to alert the public to potential safety and efficacy concerns with unapproved CBD products sold online and in stores across the country," said FDA principal deputy commissioner Dr. Amy Abernethy. "It's important that consumers understand that the FDA has only approved one drug containing CBD as an ingredient. These other, unapproved, CBD products may have dangerous health impacts and side effects. We remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD's safety. Meanwhile, we will continue to monitor and take action, as needed, against companies that unlawfully market their products — prioritizing those that pose a risk to public health."  

The FDA noted that the products covered by the warning letters had not gone through the FDA’s drug approval process and are considered unapproved new drugs. The agency also has not evaluated whether the products are effective for uses that manufacturers claim, what an appropriate dose might be, how they might interact with FDA-approved drugs or any potential side effects or safety concerns. 

The agency requested written responses from the companies within 15 working days, addressing how they will address the violations or providing reasoning and supporting information as to why they believe the products don’t violate the law. 
 

Most Popular Content

Walgreens Shifts In-Store Media Strategy

Vestcom expands its role with Walgreens as the drug chain evolves its at-shelf retail media approach.
walgreens

Michael J. Fox Voices Real Canadian Superstore's Newest Ads

The campaign is the Loblaw banner's ode to Canadian unity and strength.
real canadian superstore commercial

Retail Media in a Tariff-Impacted Economy: How to Perform, Prove and Partner

Here are some key strategies CPGs and retail media networks can implement in tough times, writes Jeffrey Bustos of Merkle.
retail media and tariffs

Ulta Beauty Sees Growth in UB Media Brand Partners, Pilots CTV, Audio & Luxury Private Marketplace

P2PI chats with Ulta Beauty’s Erin Houg on areas of opportunities and future aspirations for UB Media, the RMN’s approach to measurement, and much more.
Clinque Ulta.com Ad

Dollar General Joins Retail Media In-Housing Trend

As more retailers take ad tech under their own roof, DG seeks to scale and customize its media offerings with Kevel's API infrastructure.
dollar general kevel collab
X
This ad will auto-close in 10 seconds